Rhumbline Advisers Purchases 2,689 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Rhumbline Advisers grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 269,977 shares of the company's stock after buying an additional 2,689 shares during the quarter. Rhumbline Advisers owned 0.31% of HealthEquity worth $23,858,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity during the 4th quarter worth approximately $26,000. Transce3nd LLC purchased a new position in HealthEquity in the 4th quarter valued at approximately $29,000. Versant Capital Management Inc purchased a new position in HealthEquity in the 1st quarter valued at approximately $28,000. Smartleaf Asset Management LLC grew its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on HQY. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. The Goldman Sachs Group boosted their price target on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday. KeyCorp reduced their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Finally, JMP Securities boosted their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, HealthEquity has a consensus rating of "Buy" and a consensus price target of $118.09.

HealthEquity Price Performance

Shares of NASDAQ HQY traded down $1.15 during mid-day trading on Friday, reaching $111.55. 1,893,274 shares of the company were exchanged, compared to its average volume of 828,878. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $116.65. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $9.65 billion, a PE ratio of 102.34, a PEG ratio of 1.60 and a beta of 0.45. The company's 50 day moving average price is $91.48 and its 200 day moving average price is $97.80.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same period in the previous year, the firm posted $0.80 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.